MABS1319
Anti-Cytochrome P450 26A1 Antibody, clone F27P6A1
clone F27P6A1, from mouse
Synonym(s):
Cytochrome P450 26A1, Cytochrome P450 retinoic acid-inactivating 1, Cytochrome P450RAI, hP450RAI, Retinoic acid 4-hydroxylase, Retinoic acid-metabolizing cytochrome
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
UNSPSC Code:
12352203
eCl@ss:
32160702
biological source
mouse
Quality Level
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
F27P6A1, monoclonal
species reactivity
human
technique(s)
immunofluorescence: suitable
immunohistochemistry: suitable (paraffin)
western blot: suitable
isotype
IgG2bκ
NCBI accession no.
UniProt accession no.
shipped in
ambient
target post-translational modification
unmodified
Gene Information
human ... CYP26A1(1592)
General description
Cytochrome P450 26A1 (UniProt O43174; also known as Cytochrome P450 retinoic acid-inactivating 1, Cytochrome P450RAI, hP450RAI, Retinoic acid 4-hydroxylase, Retinoic acid-metabolizing cytochrome) is encoded by the CYP26A1 (also known as CYP26, P450RAI1) gene (Gene ID 1592) in human. CYP26A1 is a retinoic acid (RA) metabolizing enzyme that is mainly located in the endoplasmic reticulum membranes and is involved in vitamin A metabolism. It can generate several hydroxylated forms of RA, including 4-OH-RA, 4-oxo-RA and 18-OH-RA. RA is a tight binding ligand for CYP26A1 with low nM binding affinity. Higher expression of CYP26A1 is observed in the adult liver, heart, pituitary gland, placenta, and various regions of the brain. CYP26A1 activity is important for the maintenance of pregnancy, especially during the process of blastocyst implantation. Elevated CYP26A1 expression and RA catabolic activity have been detected in breast epithelial adenocarcinoma cells in culture, in leukemic cells from patients with acute promyelocytic leukemia, and in cells derived from squamous cell carcinoma.
Ref:
Han BC et al., (2010). J. Cell Physiol. 223, 471-479.
Osanai M., and Petkovich M (2005). Mol. Pharmacol. 67, 1808-1817.
Ref:
Han BC et al., (2010). J. Cell Physiol. 223, 471-479.
Osanai M., and Petkovich M (2005). Mol. Pharmacol. 67, 1808-1817.
Specificity
Target band specificity was confirmed by Western blotting of lysate from cytochrome P450 26A1-overexpressing human embryonic kidney cells (Brown, G.T., et al. (2014). PLoS One. 9(3):e90776).
Immunogen
Ovalbumin-conjugated linear peptide corresponding to a sequence near the C-terminus of human cytochrome P450 26A1 (Kumarakulasingham, M., et al. (2005). Clin. Cancer Res. 11(10):3758-3765).
Application
Anti-Cytochrome P450 26A1, clone F27P6A1, Cat. No. MABS1319, is a highly specific mouse monoclonal antibody that targets Cytochrome P450 26A1 and has been tested in Immunofluorescence, Immunohistochemistry (Paraffin), and Western Blotting.
Immunohistochemistry Analysis: A 1:250-1,000 dilution from a representative lot detected cytochrome P450 26A1 in human cerebellum, cerebral cortex, and large intestine tissue sections.
Western Blotting Analysis: 4 µg/mL from a representative lot detected cytochrome P450 26A1 in 10 µg of human liver microsome lysate.
Immunofluorescence Analysis: A representative lot immunostained dentate gyrus MAP2-positive neurons, but not GFAP-positive glia, nor CA1 hippocampal astrocytes and microglia by fluorescent immunohistochemistry staining of formalin-fixed, paraffin-embedded human hippocampus and cerebellum tissue sections (Stoney, P.N., et al. (2015). Brain Struct. Funct. In press).
Immunohistochemistry Analysis: Representative lots detected differential cytochrome P450 26A1 immunoreactivity among formalin-fixed, paraffin-embedded tissue sections from normal colon, colon cancer, and lymph node metastasis (Brown, G.T., et al. (2014). PLoS One. 9(3):e90776; Kumarakulasingham, M., et al. (2005). Clin. Cancer Res. 11(10):3758-3765).
Immunohistochemistry Analysis: A representative lot detected a significantly greater cytochrome P450 26A1 immunoreactivity among ormalin-fixed, paraffin-embedded ovarian cancer tissue sections when compared with normal ovary tissue sections (Downie, D., et al. (2005). Clin. Cancer Res.11(20):7369-7375).
Western Blotting Analysis: A representative lot detected the ~54 kDa cytochrome P450 26A1 target band in human hippocampus tissue homogenate (Stoney, P.N., et al. (2015). Brain Struct. Funct. In press).
Western Blotting Analysis: A representative lot detected the overexpression of cytochrome P450 26A1 exogenously transfected into human embryonic kidney cells (Brown, G.T., et al. (2014). PLoS One. 9(3):e90776).
Western Blotting Analysis: 4 µg/mL from a representative lot detected cytochrome P450 26A1 in 10 µg of human liver microsome lysate.
Immunofluorescence Analysis: A representative lot immunostained dentate gyrus MAP2-positive neurons, but not GFAP-positive glia, nor CA1 hippocampal astrocytes and microglia by fluorescent immunohistochemistry staining of formalin-fixed, paraffin-embedded human hippocampus and cerebellum tissue sections (Stoney, P.N., et al. (2015). Brain Struct. Funct. In press).
Immunohistochemistry Analysis: Representative lots detected differential cytochrome P450 26A1 immunoreactivity among formalin-fixed, paraffin-embedded tissue sections from normal colon, colon cancer, and lymph node metastasis (Brown, G.T., et al. (2014). PLoS One. 9(3):e90776; Kumarakulasingham, M., et al. (2005). Clin. Cancer Res. 11(10):3758-3765).
Immunohistochemistry Analysis: A representative lot detected a significantly greater cytochrome P450 26A1 immunoreactivity among ormalin-fixed, paraffin-embedded ovarian cancer tissue sections when compared with normal ovary tissue sections (Downie, D., et al. (2005). Clin. Cancer Res.11(20):7369-7375).
Western Blotting Analysis: A representative lot detected the ~54 kDa cytochrome P450 26A1 target band in human hippocampus tissue homogenate (Stoney, P.N., et al. (2015). Brain Struct. Funct. In press).
Western Blotting Analysis: A representative lot detected the overexpression of cytochrome P450 26A1 exogenously transfected into human embryonic kidney cells (Brown, G.T., et al. (2014). PLoS One. 9(3):e90776).
Research Category
Signaling
Signaling
Quality
Evaluated by Western Blotting in human hippocampus tissue lysate.
Western Blotting Analysis: 2 µg/mL of this antibody detected cytochrome P450 26A1 in 10 µg of human hippocampus tissue lysate.
Western Blotting Analysis: 2 µg/mL of this antibody detected cytochrome P450 26A1 in 10 µg of human hippocampus tissue lysate.
Target description
~53/48 kDa observed. 56.20/48.56 kDa (isoform 1/2) calculated. Uncharacterized bands may be observed in some lysate(s).
Physical form
Format: Purified
Protein G purified.
Purified mouse IgG2bκ in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Storage and Stability
Stable for 1 year at 2-8°C from date of receipt.
Other Notes
Concentration: Please refer to lot specific datasheet.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class
12 - Non Combustible Liquids
wgk_germany
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service